Search our database for a full listing of enrolling studies
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
IRB RTOG 1008 | CC CC00031 | Hospital Main Campus | Phase Phase 2 | Disease Head & Neck
IRB CASE 4311 | CC CC00192 | Hospital Main Campus | Disease Head & Neck
IRB CASE 6213 | CC 13-1422 | Hospital Fairview, Hillcrest, Main Campus, Mansfield, North Coast Cancer, Strongsville, Wooster | Disease Esophageal, Head & Neck
IRB NRG HN001 | CC 14-691 | Hospital Beachwood, Fairview, Hillcrest, Independence, Main Campus, Mansfield, North Coast Cancer, Strongsville, Wooster | Phase Phase 2, Phase 3| Disease Head & Neck
IRB CASE 6316 | CC 17-069 | Hospital Fairview, Hillcrest, Main Campus | Phase Phase 2 | Disease Head & Neck
IRB ROCH 1318 | CC 18-309 | Hospital Main Campus | Stage Advanced/Metastatic | Phase Phase 3 | Disease Head & Neck
IRB CASE 4318 | CC 18-1248 | Hospital Main Campus | Disease Head & Neck
IRB WCI 1318 | CC 18-1547 | Hospital Main Campus | Stage Recurrent/Relapsed | Phase Phase 2 | Disease Head & Neck
IRB RFI 1318 | CC 19-560 | Hospital Main Campus | Stage Recurrent/Relapsed | Phase Phase 2 | Disease Head & Neck
An underdiagnosed condition in patients with cancer
Study demonstrates superior visualization of occult primary lesions
New device offers greater tumor control for malignant liver lesions
Cleveland Clinic researchers discover what drives – and what may halt – virus-induced cancer
First-ever U.S. population-level retrospective analysis reveals many patients with systemic mastocytosis need faster intervention
New program provides prehabilitation and rehabilitation services to help patients with cancer maintain and regain function
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients